Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease release_liieq7cfefhdzk23hlvvplrcoq

by MAIARA VOLTARELLI PROVIDELLO, Zumira Aparecida Carneiro, Gisele Bulhões Portapilla, Gabriel Tavares do Vale, Ricardo Souza Camargo, Carlos Renato Tirapelli, Sérgio de Albuquerque

Published in Antimicrobial Agents and Chemotherapy by American Society for Microbiology.

2018   Volume 62

Abstract

<jats:title>ABSTRACT</jats:title> The acute phase of Chagas disease (CD) is characterized by high parasitic proliferation and intense inflammation, exacerbating the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). These reactive molecules are also increased by the metabolism of the nitroheterocyclic compounds benznidazole (BZ) and nifurtimox, the only drugs available for the treatment of CD. This oxidative environment, associated with the intracellular multiplication of <jats:named-content content-type="genus-species">Trypanosoma cruzi</jats:named-content>, leads to tissue destruction, triggering the pathogenic process. Both drugs have limited efficacy and serious side effects, which demonstrates the need to seek alternative therapies. Due to the difficulty in developing new drugs, reviewing therapeutic regimens appears advantageous, and the use of BZ in low doses associated with antioxidants, such as ascorbic acid (AA), would be a valid alternative to attenuate oxidative stress. In our <jats:italic>in vivo</jats:italic> studies, mice receiving the combination of 7.14 mg/kg of body weight/day AA and 10 mg/kg/day BZ10 (AA+BZ10) showed a reduction in parasitemia that was more effective than that with those receiving BZ or AA alone. The combined treatment was effective in decreasing intracellular ROS and lipid peroxidation in cardiac tissue. Histological and PCR analyzes showed that AA also reduced the cardiac parasitism. However, the greatest benefit was seen in AA+BZ10 group, since cardiac inflammation was significantly reduced. In addition, the combined therapy prevented the hepatic damage induced by the infection. Our findings suggest that AA combined with a low dose of BZ may improve the trypanocidal activity and attenuate the toxic effects of BZ. The decrease in oxidative damage and inflammation observed in mice treated with AA+BZ10 could result in increased cardioprotection.
In application/xml+jats format

Archived Files and Locations

application/pdf   1.0 MB
file_i4ptpgstqvfqnin3hklw24eymu
application/pdf   880.3 kB
file_g7ivbz3snfgqbncbsyiivy4q2m
web.archive.org (webarchive)
aac.asm.org (web)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2018-07-09
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0066-4804
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 6b78d942-3dfe-4a4f-a134-8238c9cdc2ee
API URL: JSON